A Study of ESO-T01 in Treating Relapsed/ Refractory Multiple Myeloma

NCT06791681 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Relapsed/ Refractory Multiple Myeloma

Interventions

DRUG: ESO-T01

Sponsor

Chunrui Li

Collaborators

[object Object]